Innovative Biotech Solutions ANGLE is a leading liquid biopsy company offering innovative diagnostic solutions for cancer research, drug development, and clinical oncology. Its patented Parsortix® PC1 System allows complete analysis of circulating tumor cells using a simple blood sample, presenting a key opportunity for institutions and researchers in need of advanced cancer diagnostics.

Diversified Revenue Streams With commercial focuses on both diagnostic products and clinical services, ANGLE offers a diverse range of revenue-generating opportunities. This diversity, including the Parsortix® system and clinical laboratory services, provides a broader sales scope for businesses seeking partnerships in the biotechnology and oncology sectors.

Established Credibility through Publications ANGLE's Parsortix system has been extensively validated through over 80 peer-reviewed publications, enhancing the company's credibility and market reputation. Leveraging this established track record can open doors for sales representatives targeting institutions that value proven and reliable technologies in their oncology research and diagnostics.

Strategic Market Presence ANGLE has strategically positioned itself in the biotechnology and research market, offering not only diagnostic products but also clinical trial testing and assay development services. This multifaceted presence creates prime sales opportunities for B2B partnerships with pharmaceutical companies, research institutions, and clinical laboratories seeking cutting-edge solutions for cancer analysis.

Potential for Expansion and Collaboration With significant funding and revenue between $10M and $50M, ANGLE stands poised for expansion and collaboration. Sales professionals can capitalize on this financial stability to present partnership opportunities, joint ventures, and technology collaborations that leverage ANGLE's capabilities and market positioning for mutual growth and success.